EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical and Neurophysiological Effects of Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Depression

Luke J Hearne, Lachlan Webb, Robin Cash, Conor Robinson, Philip E Mosley, Joanna Ng, Simon T Thwaites, Simon Issa, Jessica Miller, Nga Yan Tse, Andrew Zalesky, Bjorn Burgher und 1 weitere

Psychotherapy and Psychosomatics · 09.04.2025 · 94 (4) · 225-231

DOI: 10.1159/000545692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychotherapy and Psychosomatics, online erschienen am 09.04.2025. Verfasst von Luke J Hearne und 12 weiteren Autor:innen. Beteiligte Einrichtung: QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Major Depressive Disorder, Magnetic Resonance Imaging, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is an established treatment for refractory major depressive disorder (MDD), but treatment outcomes vary substantially from person to person. Recent evidence suggests that incorporating neuroimaging-based targeting may help improve clinical outcomes. Here, we report the initial clinical outcomes of our open-label fMRI-personalized treatment protocol from the Queensland Neurostimulation Centre.

Methods

This open-label, nonrandomized study was conducted between November 2021 and September 2024. Participants were a referred sample aged between 19 and 84, meeting the criteria for treatment-resistant MDD (N = 61). They received 20- or 30-weekday sessions of DLPFC rTMS. The stimulation site was personalized using each individual’s fMRI brain connectivity data.

Results

The primary outcome was change in the Montgomery-Åsberg Depression Rating Scale (MADRS). MADRS was lower post-treatment (d = 1.78, p < 0.001), with 52% and 33% response and remission rates observed. Likewise, anxiety scores (Hamilton Anxiety Rating Scale) were lower post-treatment (d = 1.27, p < 0.001), with 46% and 28% response and remission rates observed. The treatment was most effective in patients who qualified for randomized controlled trials (RCTs; N = 19, MADRS response = 74%, remission = 53%) and least effective in patients with bipolar or neurological disorders (N = 8, MADRS response = 38%, remission = 25%). Neurophysiologically, functional brain connectivity in the personalized DLPFC-subgenual cingulate cortex pathway was less anticorrelated post-treatment (d = 0.63, p < 0.001).

Conclusion

Our findings provide new clinical and neurophysiological evidence supporting the high effectiveness of fMRI connectivity-guided personalized rTMS for MDD, especially in individuals without complex comorbidities. The results encourage future RCTs to assess the superiority of personalized targeting over standard TMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Magnetic StimulationMajor Depressive DisorderMagnetic Resonance ImagingDepressive Disorder, Treatment-ResistantDorsolateral Prefrontal CortexRoboticsHumansFemaleMaleAdultMiddle AgedAgedTreatment OutcomeYoung AdultAged, 80 and overPrecision Medicine

Stichwörter der Autor:innen

DepressionPersonalizationPrecision medicineTrascranial magnetic stimulationfMRI

Autor:innen und Institutionen

  • QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.
  • Queensland Neurostimulation Centre, Brisbane, Queensland, Australia.
  • Melbourne Neuropsychiatry Centre, Department of Biomedical Engineering, The University of Melbourne, Melbourne, Victoria, Australia.
  • The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Queensland, Australia.

Zitieren

APA

Hearne, L. J., Webb, L., Cash, R., Robinson, C., Mosley, P. E., Ng, J., Thwaites, S. T., Issa, S., Miller, J., Yan Tse, N., Zalesky, A., Burgher, B., & Cocchi, L. (2025). Clinical and Neurophysiological Effects of Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Depression. Psychotherapy and Psychosomatics, 94(4), 225-231. https://doi.org/10.1159/000545692

Vancouver

Hearne LJ, Webb L, Cash R, Robinson C, Mosley PE, Ng J, et al. Clinical and Neurophysiological Effects of Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Depression. Psychotherapy and Psychosomatics. 2025;94(4):225-231. doi:10.1159/000545692

BibTeX
@article{Hearne2025,
  author = {Hearne, Luke J and Webb, Lachlan and Cash, Robin and Robinson, Conor and Mosley, Philip E and Ng, Joanna and Thwaites, Simon T and Issa, Simon and Miller, Jessica and Yan Tse, Nga and Zalesky, Andrew and Burgher, Bjorn and Cocchi, Luca},
  title = {Clinical and Neurophysiological Effects of Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Depression},
  journal = {Psychotherapy and Psychosomatics},
  year = {2025},
  volume = {94},
  number = {4},
  pages = {225--231},
  doi = {10.1159/000545692}
}
Kostenlos starten →